Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

<p>Aims: Ventricular arrhythmia triggers sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM), yet electrophysiological biomarkers are not used for risk stratification. Our aim was to identify distinct HCM phenotypes based on ECG computational analysis, and characterize differences...

Full description

Bibliographic Details
Main Authors:	Lyon, A, Ariga, R, Minchole, A, Mahmod, M, Ormondroyd, E, Laguna, P, de Freitas, N, Neubauer, S, Watkins, H, Rodriguez, B
Format:	Journal article
Published:	Frontiers Media 2018

Similar Items

Risk stratification in hypertrophic cardiomyopathy based on QRS and T wave morphological biomarkers identifies three phenotypic subgroups
by: Lyon, A, et al.
Published: (2016)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
by: Chow, J, et al.
Published: (2024)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
by: Ji-Jian Chow, et al.
Published: (2024-08-01)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
by: Lyon, A, et al.
Published: (2018)

Extraction of morphological QRS-based biomarkers in hypertrophic cardiomyopathy for risk stratification using L1 regularized logistic regression
by: Lyon, A, et al.
Published: (2016)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
by: Passini, E, et al.
Published: (2015)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
by: Zakariye Ashkir, MD, et al.
Published: (2024-01-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: Coleman, JA, et al.
Published: (2024)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: James A. Coleman, et al.
Published: (2024-04-01)

ECG-based estimation of dispersion of APD restitution as a tool to stratify sotalol-induced arrhythmic risk.
by: Mincholé, A, et al.
Published: (2015)

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
by: Coleman, JA
Published: (2024)

Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
by: Masliza Mahmod, et al.
Published: (2022-06-01)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
by: Safa Daghem, et al.
Published: (2024-01-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
by: S. M. Komissarova, et al.
Published: (2021-05-01)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
by: Ariga, R, et al.
Published: (2017)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
by: Ariga, R, et al.
Published: (2018)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
by: Ariga, R, et al.
Published: (2019)

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
by: Coleman, J
Published: (2024)

Pseudo-arrhythmic ECG artifact
by: Satyajeet Singh, et al.
Published: (2012-01-01)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
by: Sílvia Aguiar Rosa, et al.
Published: (2021-12-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
by: Neubauer, S, et al.
Published: (2019)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

Distinct Phenotypic Groups and Related Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
by: Soongu Kwak, et al.
Published: (2024-10-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
by: Neubauer, S, et al.
Published: (2019)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
by: George Joy, MD, et al.
Published: (2024-01-01)

Discrepancy between pathological progression and clinical stability in a young patient with hypertrophic cardiomyopathy
by: Raman, B, et al.
Published: (2018)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
by: Raman, B, et al.
Published: (2018)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
by: Lyon, A, et al.
Published: (2019)

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
by: Raman, B, et al.
Published: (2021)

Computational techniques for ECG analysis and interpretation in light of their contribution to medical advances
by: Lyon, A, et al.
Published: (2018)

Restrictive cardiomyopathy and hypertrophic cardiomyopathy overlap: the importance of the phenotype
by: Juan Pablo Kaski, et al.
Published: (2012-10-01)

Sudden death in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2000)

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.
by: Petersen, SE, et al.
Published: (2009)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
by: Doste, R, et al.
Published: (2022)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
by: Coleman, J, et al.
Published: (2023)

Atypical ECG Presentation of Hypertrophic Cardiomyopathy stimulating Acute Myocardial Infarction
by: Rikesh Tamrakar
Published: (2021-04-01)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
by: Raman, B, et al.
Published: (2017)

A Genotype-phenotype Taxonomy of Hypertrophic Cardiomyopathy
by: Lara Curran, BSc, et al.
Published: (2024-01-01)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2001)